Abnormal cytogenetic clones in patients with aplastic anaemia: response to immunosuppressive therapy
- 1 February 1999
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 104 (2) , 271-274
- https://doi.org/10.1046/j.1365-2141.1999.01187.x
Abstract
We report the response to immunosuppressive therapy with antithymocyte globulin (ATG) and cyclosporin or oxymetholone in 13 cases of aplastic anaemia (AA) with an abnormal cytogenetic clone detected at or sometime after diagnosis. Blood and bone marrow examination showed no distinctive morphological features of myelodysplasia (MDS) at diagnosis. Haematological response occurred promptly in eight cases; the remainder responded after additional immunosuppression with or without oxymetholone. Three patients had a late relapse of AA, treated successfully by allogeneic bone marrow transplantation in one; the others responded to oxymetholone. Transformation to MDS or acute leukaemia was not observed after a median follow-up of 4.1 years (range 1.2-11.2). In four patients the cytogenetic clone disappeared after treatment.Keywords
This publication has 6 references indexed in Scilit:
- Antithymocyte globulin for patients with myelodysplastic syndromeBritish Journal of Haematology, 1997
- Hypocellular myelodysplastic syndromes (MDS): new proposalsBritish Journal of Haematology, 1995
- The treatment of severe acquired aplastic anemiaBlood, 1995
- Malignant Tumors Occurring after Treatment of Aplastic AnemiaNew England Journal of Medicine, 1993
- Trisomy 6: a recurring cytogenetic abnormality associated with marrow hypoplasia [letter]Blood, 1991